fbpx

Immunotherapy and
the Future of Cancer
Treatment.

RECENT NEWS

Dr. Nasha Winters’ Mission to Create a New Standard of Cancer Treatment

For decades, Dr. Nasha Winters has been a dynamic force in the field of integrative…

Mathew Halpert, PhD
Overcoming Adversity: Al’s Journey Fighting Stage 4 Pancreatic Cancer

On March 31, 2021, Al received his diagnosis: Stage 4 pancreatic cancer. And to make…

Mathew Halpert, PhD
A Journey of Hope: Lynn’s Battle with Triple Negative Breast Cancer

In June of 2020, Lynn’s world shifted completely when she received a diagnosis of triple…

Mathew Halpert, PhD
Keeping the Faith: Kareema’s Fight Against Stage 4 Neuroendocrine Cancer

Kareema’s journey began in 2021 with a sobering diagnosis of terminal stage four Neuroendocrine cancer.…

Mathew Halpert, PhD
Taking Back the Power: Sheryl’s Journey with Stage 4 Breast Cancer

In 2012, Sheryl was diagnosed with metastatic breast cancer. She went through the traditional treatment…

Mathew Halpert, PhD
UNDERSTANDING CANCER
Your Immune System Can Fight Cancer

It seems most people are aware that the Immune System fights everyday to keep viruses…

Mathew Halpert, PhD
Advances in Treating Triple-Negative Breast Cancer

Triple-negative breast cancer is a unique form of breast cancer lacking in typical receptors found…

Mathew Halpert, PhD
Using Dendritic Cells to Fight Head and Neck Cancers

Head and Neck Cell Cancers (HNC) includes cancers within the oral cavity, sinonasal cavities, pharynx…

Mathew Halpert, PhD
Understanding Immunotherapy with World Renowned Author, Haylie Pomroy

The Immunocine Team’s Dr. Matt Halpert and Dr. Rafael Gonzalez recently recorded a podcast with…

Mathew Halpert, PhD
The Misconception of Checkpoint Inhibitors

As the earliest form of commercialized Immunotherapy, Checkpoint Inhibitors laid the foundation for Immunotherapy as…

Mathew Halpert, PhD
Is Alternative Cancer Treatment Safe and Effective?

As we now live in an age in which information freely flows and all manners…

Mathew Halpert, PhD
Dendritic Cells and Their Therapeutic Role in Prostate Cancer

In 2022, almost 270,000 American men will be diagnosed with prostate cancer, and about 35,000…

Mathew Halpert, PhD
Immunocine Dendritic Cell Therapy for Colorectal Cancers

Colorectal cancers have been on the rise and now afflict more than 2 million humans…

Mathew Halpert, PhD
TREATMENT AT IMMUNOCINE
Preparing for Your Trip and Treatment

It’s time to fight this cancer, fight it on your terms, and fight it hard.…

Mathew Halpert, PhD
Is this therapy available in the US?

With the variety of treatment options in the states, you may wonder why you can’t…

Mathew Halpert, PhD
Why Is Immunocine in Cancun, Mexico?

Alternative treatment centers are often met with a skeptical eye, and with justifiable reason.

Mathew Halpert, PhD
Immunotherapy vs. Chemotherapy Side Effects: Comparing the Objectives

On August 4th, we posted an overview of how chemotherapeutic side effects differ from those…

Mathew Halpert, PhD
WELLNESS & NUTRITION
Nourishing Hope: The Vital Role of Nutrition During Cancer Treatment

Cancer is a formidable opponent that affects millions of lives worldwide. While advancements in medical…

Mathew Halpert, PhD
Could Curcumin Really Help Cure Cancer?

Cancer is a complex disease that affects millions of people worldwide. While conventional cancer treatments…

Mathew Halpert, PhD
EGCG and Green Tea Protect Anti-Tumor Immunity

Epigallocatechin gallate (EGCG) is the most abundant catechin in green tea, and one of the most…

Mathew Halpert, PhD
Hyperbaric Oxygen Therapy and Cancer Treatment

The relationship between cancer and oxygen is complicated, and nothing written here is going to…

Mathew Halpert, PhD
Shining the Light on Vitamin D and Cancer Treatment

Worryingly, about 35-45% of Americans don’t have enough Vitamin D11, the essential nutrient that our…

Mathew Halpert, PhD
Boosting Immunotherapy with Dietary Fiber

Of the 1.9 million cancer patients in 2021, 600,000 received immunotherapy, a remarkable number given…

Mathew Halpert, PhD
Diet Guide to Prepare for Immunotherapy

As cancer patients prepare to come to Cancun to begin their personalized Immunotherapy journey, they…

Mathew Halpert, PhD
PATIENT STORIES
Martin’s Success Story Fighting Stage 3B Prostate Cancer with Immunocine

In 2018, Martin’s life took an unexpected turn when he received a diagnosis of prostate…

Mathew Halpert, PhD
Overcoming Adversity: Al’s Journey Fighting Stage 4 Pancreatic Cancer

On March 31, 2021, Al received his diagnosis: Stage 4 pancreatic cancer. And to make…

Mathew Halpert, PhD
A Journey of Hope: Lynn’s Battle with Triple Negative Breast Cancer

In June of 2020, Lynn’s world shifted completely when she received a diagnosis of triple…

Mathew Halpert, PhD
Keeping the Faith: Kareema’s Fight Against Stage 4 Neuroendocrine Cancer

Kareema’s journey began in 2021 with a sobering diagnosis of terminal stage four Neuroendocrine cancer.…

Mathew Halpert, PhD
Taking Back the Power: Sheryl’s Journey with Stage 4 Breast Cancer

In 2012, Sheryl was diagnosed with metastatic breast cancer. She went through the traditional treatment…

Mathew Halpert, PhD
Life After Cancer: Babette’s Journey with Stage 4 Ovarian Cancer

When Babette received the diagnosis of terminal stage 4 ovarian cancer, her world was turned…

Mathew Halpert, PhD
Stage 4 Prostate Cancer Patient Update after 5 Years

In 2014, Chris had Stage 4 Metastatic Prostate Cancer that had spread throughout his body.…

Mathew Halpert, PhD
Babette’s Treatment Experience with Immunocine

Many of our patients are pleasantly surprised by how much they enjoy their time in…

Babette Lamarre
RESEARCH
A Revolutionary Approach to Cancer Treatments

Immunocine’s Dendritic Cell Treatment represents a huge step forward in Immunotherapy and utilizing Dendritic Cells…

Mathew Halpert, PhD
Cancer Cells Hiding in Other Cancer Cells?

As we outlined in our post dedicated to Head & Neck Cancer, the Immune System…

Mathew Halpert, PhD
What Is Immunotherapy?

In the late 1800’s Dr. William Coley stumbled onto an interesting observation, that an active…

Mathew Halpert, PhD
Why don’t Checkpoint Inhibitors Work More Often?

With immunotherapy really taking off in the past decade, many cancer patients are rightfully interested…

Mathew Halpert, PhD